Mutual regulation of Bcl-2 proteins independent of the BH3 domain as shown by the BH3-lacking protein Bcl-x AK

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Plötz, Michael ^a   Hossini, Amir M ^a   Gillissen, Bernhard ^a   Daniel, Peter T ^a   Stockfleth, Eggert ^a   Eberle, Jürgen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; CYTOCHROME C; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BCL XAK; PROTEIN NOXA; PUMA PROTEIN; UNCLASSIFIED DRUG; BAK1 PROTEIN, HUMAN; BAX PROTEIN (53 86); BAX PROTEIN (53-86); CASPASE; MEMBRANE PROTEIN; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTEIN BAK;

ADENOVIRUS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL DEATH; CLUSTER ANALYSIS; CONTROLLED STUDY; EXPRESSION VECTOR; HUMAN; HUMAN CELL; MELANOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN CONFORMATION; PROTEIN DEFECT; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; PROTEIN TRANSPORT; GENETICS; METABOLISM; MITOCHONDRION; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-X PROTEIN; CASPASES; CELL LINE, TUMOR; CYTOCHROMES C; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE PROTEINS; MITOCHONDRIA; PEPTIDE FRAGMENTS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84859595844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034549     Document Type: Article

References (49)

1. Vogler M, Weber K, Dinsdale D, Schmitz I, Schulze-Osthoff K, et al. (2009) Different forms of cell death induced by putative BCL2 inhibitors. Cell Death Differ 16: 1030-1039.
2. Eberle J, Kurbanov BM, Hossini AM, Trefzer U, Fecker LF, (2007) Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches. Drug Resist Updat 10: 218-234.
3. Gogvadze V, Orrenius S, Zhivotovsky B, (2008) Mitochondria in cancer cells: what is so special about them? Trends in Cell Biology 18: 165-173.
4. Krammer PH, Arnold R, Lavrik IN, (2007) Life and death in peripheral T cells. Nat Rev Immunol 7: 532-542.
5. Tait SW, Green DR, (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11: 621-632.
6. Fischer U, Janicke RU, Schulze-Osthoff K, (2003) Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 10: 76-100.
7. Riedl SJ, Shi Y, (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5: 897-907.
8. van Delft MF, Huang DC, (2006) How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res 16: 203-213.
9. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR, (2010) The BCL-2 family reunion. Mol Cell 37: 299-310.
10. Willis SN, Adams JM, (2005) Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17: 617-625.
11. Gallenne T, Gautier F, Oliver L, Hervouet E, Noel B, et al. (2009) Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members. J Cell Biol 185: 279-290.
12. Eberle J, Hossini AM, (2008) Expression and function of bcl-2 proteins in melanoma. Curr Genomics 9: 409-419.
13. Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, et al. (2001) The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol 117: 333-340.
14. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, et al. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608.
15. Hossini AM, Geilen CC, Fecker LF, Daniel PT, Eberle J, (2006) A novel Bcl-x splice product, Bcl-xAK, triggers apoptosis in human melanoma cells without BH3 domain. Oncogene 25: 2160-2169.
16. Carey TE, Takahashi T, Resnick LA, Oettgen HF, Old LJ, (1976) Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A 73: 3278-3282.
17. Bruggen J, Sorg C, (1983) Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies. Cancer Immunol Immunother 15: 200-205.
18. Gillissen B, Essmann F, Hemmati PG, Richter A, Richter A, et al. (2007) Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis. J Cell Biol 179: 701-715.
19. Gillissen B, Essmann F, Graupner V, Starck L, Radetzki S, et al. (2003) Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway. EMBO J 22: 3580-3590.
20. Fecker LF, Ruckert S, Kurbanov BM, Schmude M, Stockfleth E, et al. (2011) Efficient Melanoma Cell Killing and Reduced Melanoma Growth in Mice by a Selective Replicating Adenovirus Armed with Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand. Human Gene Therapy 22: 405-417.
21. Riccardi C, Nicoletti I, (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 1: 1458-1461.
22. Eberle J, Fecker LF, Hossini AM, Wieder T, Daniel PT, et al. (2003) CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants. Oncogene 22: 9131-9141.
23. Youle RJ, Karbowski M, (2005) Mitochondrial fission in apoptosis. Nature Reviews Molecular Cell Biology 6: 657-663.
24. Akgul C, Moulding DA, Edwards SW, (2004) Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications. Cell Mol Life Sci 61: 2189-2199.
25. Ewings KE, Wiggins CM, Cook SJ, (2007) Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels. Cell Cycle 6: 2236-2240.
26. Moore MJ, Wang Q, Kennedy CJ, Silver PA, (2010) An alternative splicing network links cell-cycle control to apoptosis. Cell 142: 625-636.
27. Schmitt E, Paquet C, Beauchemin M, Bertrand R, (2004) Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation. Oncogene 23: 3915-3931.
28. Shkreta L, Michelle L, Toutant J, Tremblay ML, Chabot B, (2010) The DNA damage response pathway regulates the alternative splicing of the apoptotic mediator Bcl-x. J Biol Chem.
29. Slee EA, Keogh SA, Martin SJ, (2000) Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release. Cell Death Differ 7: 556-565.
30. Merino D, Giam M, Hughes PD, Siggs OM, Heger K, et al. (2009) The role of BH3-only protein Bim extends beyond inhibiting Bcl-2-like prosurvival proteins. J Cell Biol 186: 355-362.
31. Zhai D, Jin C, Huang Z, Satterthwait AC, Reed JC, (2008) Differential regulation of Bax and Bak by anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1. J Biol Chem 283: 9580-9586.
32. Kim TH, Zhao Y, Ding WX, Shin JN, He X, et al. (2004) Bid-cardiolipin interaction at mitochondrial contact site contributes to mitochondrial cristae reorganization and cytochrome C release. Mol Biol Cell 15: 3061-3072.
33. Chipuk JE, Green DR, (2008) How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18: 157-164.
34. Lindenboim L, Kringel S, Braun T, Borner C, Stein R, (2005) Bak but not Bax is essential for Bcl-xS-induced apoptosis. Cell Death Differ 12: 713-723.
35. Hossini AM, Eberle J, Fecker LF, Orfanos CE, Geilen CC, (2003) Conditional expression of exogenous Bcl-X(S) triggers apoptosis in human melanoma cells in vitro and delays growth of melanoma xenografts. FEBS Lett 553: 250-256.
36. Oppermann M, Geilen CC, Fecker LF, Gillissen B, Daniel PT, et al. (2005) Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk/Bik. Oncogene 24: 7369-7380.
37. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, et al. (2001) BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8: 705-711.
38. Kim H, Tu HC, Ren D, Takeuchi O, Jeffers JR, et al. (2009) Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell 36: 487-499.
39. Billen LP, Shamas-Din A, Andrews DW, (2008) Bid: a Bax-like BH3 protein. Oncogene 27 (Suppl 1): S93-104.
40. Chipuk JE, Bouchier-Hayes L, Green DR, (2006) Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death and Differentiation 13: 1396-1402.
41. Green DR, Kroemer G, (2004) The pathophysiology of mitochondrial cell death. Science 305: 626-629.
42. Mikhailov V, Mikhailova M, Degenhardt K, Venkatachalam MA, White E, et al. (2003) Association of Bax and Bak homo-oligomers in mitochondria- Bax requirement for Bak reorganization and cytochrome c release. Journal of Biological Chemistry 278: 5367-5376.
43. Martinou JC, Youle RJ, (2011) Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics. Developmental Cell 21: 92-101.
44. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, et al. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381: 335-341.
45. Du H, Wolf J, Schafer B, Moldoveanu T, Chipuk JE, et al. (2010) BH3-domains other than Bim and Bid can directly activate BAX/BAK. J Biol Chem.
46. Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, et al. (2006) Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8: 1348-1358.
47. Lomonosova E, Chinnadurai G, (2008) BH3-only proteins in apoptosis and beyond: an overview. Oncogene 27 (Suppl 1): S2-19.
48. Vande VC, Cizeau J, Dubik D, Alimonti J, Brown T, et al. (2000) BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 20: 5454-5468.
49. Weber A, Paschen SA, Heger K, Wilfling F, Frankenberg T, et al. (2007) BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins. J Cell Biol 177: 625-636.